• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPfizer

Pfizer

Page 28 of 37
Vials of AstraZeneca's Covid-19 vaccine.
HealthWith AstraZeneca’s COVID-19 vaccine trials on hold in the U.S., a gulf widens between America and other countries
By Jeremy KahnOctober 2, 2020
ConferencesHow 3 of biopharma’s most powerful women are building public trust during COVID
By Sy MukherjeeSeptember 29, 2020
Magazine‘The whole world is coming together’: How the race for a COVID vaccine is revolutionizing Big Pharma
By Clifton LeafSeptember 21, 2020
Coronavirus Vaccine Research at Valneva SA Labs
NewslettersThe rollercoaster of COVID-19 vaccines
By Sy MukherjeeSeptember 10, 2020
Close-up of someone receiving a vaccination.
HealthCOVID-19 vaccine still on track for later this year despite trial pause, AstraZeneca CEO says
By Jeremy KahnSeptember 10, 2020
CEO of Pfizer Inc. Albert Bourla, DVM, Ph.D. attends 2019 Forbes Healthcare Summit at the Jazz at Lincoln Center on December 05, 2019 in New York City.
NewslettersPfizer’s Albert Bourla: Vaccine efforts are improving Big Pharma’s reputation
By David Meyer and Alan MurraySeptember 10, 2020
NewslettersGlobal markets dip as investors again sour on tech stocks
By Bernhard WarnerSeptember 10, 2020
Pfizer coronavirus vaccine Fortune
HealthPfizer’s CEO is still hopeful for COVID vaccine progress by October—and says a sense of purpose is fueling him
By Sy MukherjeeSeptember 9, 2020
Image of a syringe injecting a coronavirus in front of an American flag.
HealthTrump wants a COVID-19 vaccine by Election Day. But will one be ready?
By Jeremy KahnSeptember 4, 2020
FinanceSalesforce, Amgen, and Honeywell Int’l will join Dow Jones Industrial Average
By Andrew NuscaAugust 24, 2020
Woman in a white lab coat and pink rubber gloves holding a vial of purple liquid.
HealthScientists to Wall Street: You don’t really understand how COVID vaccine tests work
By Jeremy KahnAugust 24, 2020
Syringe shown against the AstraZeneca logo
HealthAstraZeneca denies it is in discussions to fast-track U.S. approval of its COVID-19 vaccine
By Jeremy KahnAugust 24, 2020
HealthU.S. government secures 100 million doses of Pfizer, BioNTech vaccine for $2 billion
By John Lauerman and BloombergJuly 22, 2020
Pfizer New York Headquarters - Pfizer announced a $14
Newsletters3 coronavirus stocks jump on vaccine news
By Sy MukherjeeJuly 13, 2020
FinanceA dose of good news: Pfizer shares surge on coronavirus vaccine trial
By Rey MashayekhiJuly 1, 2020
1...
  • 26
  • 27
  • 28
  • 29
  • 30
...37
Most Popular
Law
DOGE cancelled a $349,000 grant to replace a museum’s HVAC after ChatGPT flagged it as DEI, court documents showAn image of a popular article
By Fortune EditorsMarch 19, 2026
Economy
Social Security has 6 years left. The fix that sounds cruelest may be the smartestAn image of a popular article
By Fortune EditorsMarch 19, 2026
Economy
Jerome Powell says you're right to blame data centers for making your bills more expensive: 'probably pushing inflation up'An image of a popular article
By Fortune EditorsMarch 19, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.